Cardiolipin Antibodies Panel IgG & IgM is a blood test that detects IgG and IgM antibodies directed against cardiolipin, a type of phospholipid. These antibodies are associated with antiphospholipid syndrome (APS), an autoimmune condition that can increase the risk of abnormal blood clots and certain pregnancy complications. The test is needed to evaluate suspected APS, particularly in individuals with unexplained thrombosis or recurrent pregnancy-related complications.
Cardiolipin antibodies are autoantibodies that target cardiolipin, a phospholipid associated with cell membranes. Their presence can be associated with an increased tendency toward abnormal blood clotting in some individuals.
IgG and IgM are different classes of antibodies. Both can be detected in antiphospholipid antibody testing, and their significance depends on antibody levels, persistence, and the individual's clinical history.
A positive IgG result means cardiolipin-specific IgG antibodies were detected. It does not independently establish an APS diagnosis and requires clinical correlation and appropriate follow-up testing.
A positive IgM result indicates that cardiolipin-specific IgM antibodies were detected. Temporary positivity can occur, so the result must be interpreted alongside symptoms and other laboratory findings.
No. APS diagnosis involves both appropriate clinical events and laboratory evidence. A positive cardiolipin antibody result alone is not sufficient to diagnose the condition.
